Lantheus to Share Innovations at Major Healthcare Conference

Lantheus to Present at the Jefferies London Healthcare Conference

BEDFORD, Mass. — Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), a leader in the field of radiopharmaceuticals, is excited to announce that Bob Marshall, the Chief Financial Officer and Treasurer, will be representing the company at the upcoming Jefferies London Healthcare Conference. His presentation is scheduled for 1:00 p.m. GMT (8 a.m. EST) on a Wednesday in late November.

What to Expect from the Presentation

During this presentation, Lantheus will focus on its innovative radiopharmaceutical solutions that are designed to enable clinicians to effectively Find, Fight, and Follow diseases. This mission is at the heart of Lantheus’s commitment to improving patient outcomes and transforming healthcare practices.

Understanding Radiopharmaceuticals

Radiopharmaceuticals integrate radioactive substances with pharmaceutical compounds to target specific diseases or conditions within the body. Lantheus has been pioneering this approach for over 65 years, providing critical tools that enhance the diagnostic and therapeutic capabilities in medicine.

Company Commitment to Healthcare

Lantheus plays a vital role in the healthcare ecosystem by offering products that help in the early detection and management of serious diseases. The company's investments in research and development have allowed it to remain at the forefront of the industry.

Live Webcast Access and Replay Availability

To engage with Lantheus during the Jefferies Healthcare Conference, interested parties can access the live webcast via the Investors section of the company’s official website. Furthermore, a replay of the presentation will be accessible on the site for a minimum of 30 days post-event. This flexibility ensures that a broader audience can benefit from the insights shared during the conference.

About Lantheus Holdings, Inc.

Lantheus has solidified its position as a foremost radiopharmaceutical-focused company, delivering groundbreaking science to improve the healthcare journey. With headquarters located in Massachusetts and additional offices in Canada and Sweden, Lantheus's global presence enhances its ability to serve communities effectively. Their commitment to delivering state-of-the-art radiopharmaceutical solutions underscores their long-standing dedication to fostering better patient outcomes.

Reach Out to Lantheus

For those wishing to learn more about Lantheus's innovations or to inquire about their radiopharmaceutical offerings, the company’s representatives are readily available. Mark Kinarney, Vice President of Investor Relations, can be reached at 978-671-8842. Additionally, for communication related to media inquiries, Melissa Downs, Senior Director of External Communications, is on hand at 646-975-2533.

Frequently Asked Questions

What is the main focus of Lantheus at the conference?

Lantheus will showcase its advancements in radiopharmaceuticals aimed at improving disease detection and management.

Who will represent Lantheus at the conference?

Bob Marshall, the Chief Financial Officer and Treasurer of Lantheus, will present at the conference.

How can I access the live presentation?

The live presentation can be accessed through the Investors section of Lantheus's official website.

Will the presentation be available after the event?

Yes, there will be a replay available on the Lantheus website for at least 30 days following the live presentation.

What is the mission statement of Lantheus?

Lantheus aims to enable clinicians to Find, Fight, and Follow disease, ultimately leading to better patient outcomes.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.